针对纤维细胞激活蛋白载体细胞的治疗术:进展和挑战
Sahar Rezaei1, Esmaeil Gharapapagh2, Shahram Dabiri2
1Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Nuclear Medicine, Faculty of Medicine, Imam Reza General Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
Life sciences
|July 22, 2023
概括
在癌症中准纤维细胞激活蛋白 (FAP) 提供了新的治疗方法. 本综述强调了针对FAP的生物标志物和瘤学成像学的进展,改善了癌症检测和治疗.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 生物标志物发现发现
背景情况:
- 瘤微环境 (TME) 显著影响癌症的进展.
- 在TME内的癌症相关纤维细胞 (CAF) 促进瘤生长和转移.
- 纤维细胞激活蛋白 (FAP) 被CAFs高度表达,并与不良癌症结果相关.
研究的目的:
- 审查针对癌症治疗药物的FAP的最新进展.
- 探索FAP作为瘤学中的治疗目标.
- 讨论用于针对FAP的检测和治疗的成像方法.
主要方法:
- 关于癌症中FAP向的当前文献的综述.
- 讨论了针对FAP的各种theranostic生物标志物.
- 图像技术的概述,包括SPECT,PET,CT,光和MRI.
主要成果:
- FAP是癌症检测和治疗的一个有前途的生物标志物.
- 针对FAP的治疗方法在临床前和临床环境中显示出潜力.
- 先进的成像模式可以实现精确的可视化和治疗监控.
结论:
- 向FAP代表了瘤学中一个重要的治疗战略.
- 结合FAP生物标志物和先进的成像技术,可以改善癌症管理.
- 进一步研究针对FAP的治疗药物对于改善患者的治疗结果至关重要.
相关概念视频
Introduction to Fibroblasts
3.1K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.1K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


